Annexon logo

Annexon Share Price Today

(NASDAQ: ANNX)

Annexon share price is $2.78 & ₹241.77 as on 6 Mar 2025, 2.30 'hrs' IST

$2.78

0.31

(12.55%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Annexon share price in Dollar and Rupees. Guide to invest in Annexon stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Annexon, along with analyst recommendations, forecasts, and comprehensive financials.

Annexon share price movements

  • Today's Low: $2.45
    Today's High: $2.79

    Day's Volatility :12.19%

  • 52 Weeks Low: $2.39
    52 Weeks High: $8.40

    52 Weeks Volatility :71.55%

Annexon (ANNX) Returns

PeriodAnnexon IncSector (Health Care)Index (Russel 2000)
3 Months
-51.28%
2.1%
0.0%
6 Months
-57.56%
-4.1%
0.0%
1 Year
-52.86%
2.2%
0.0%
3 Years
-43.22%
11.8%
-11.6%

Annexon (ANNX) Key Statistics

in dollars & INR

Previous Close
$2.47
Open
$2.46
Today's High
$2.79
Today's Low
$2.45
Market Capitalization
$254.8M
Today's Volume
$626.1K
52 Week High
$8.4
52 Week Low
$2.39
Revenue TTM
$0.0
EBITDA
$-129.5M
Earnings Per Share (EPS)
$-1.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-48.12%

How to invest in Annexon Stock (ANNX) from India?

It is very easy for Indian residents to invest directly in Annexon from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Annexon stock in both Indian Rupees (INR) and US Dollars (USD). Search for Annexon or ANNX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Annexon or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Annexon shares which would translate to 0.313 fractional shares of Annexon as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Annexon, in just a few clicks!

Returns in Annexon (ANNX) for Indian investors in Rupees

The Annexon stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Annexon investment value today

Current value as on today

₹58,016

Returns

₹41,984

(-41.98%)

Returns from Annexon Stock

₹46,947 (-46.95%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Annexon (ANNX)

233%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Annexon Stock from India on INDmoney has increased by 233% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Annexon

  • FMR Inc

    13.34%

  • BlackRock Inc

    7.96%

  • SATTER MANAGEMENT CO., L.P.

    6.95%

  • Bvf Inc

    6.57%

  • Redmile Group, LLC

    5.91%

  • Point72 Asset Management, L.P.

    5.28%

Analyst Recommendation on Annexon

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Annexon(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
12
12
Hold
1
2
2
Sell
0
0
0

Analyst Forecast on Annexon Stock (ANNX)

What analysts predicted

Upside of 445.56%

Target:

$15.17

Current:

$2.78

Insights on Annexon Stock (Ticker Symbol: ANNX)

  • Price Movement

    In the last 1 month, ANNX stock has moved down by -33.2%
  • ANNX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 116.1%
  • ANNX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 90.5%

Annexon Technicals Summary

Sell

Neutral

Buy

Annexon is currently in a neutral trading position according to technical analysis indicators.

Annexon (ANNX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Annexon Inc logo
-29.83%
-57.56%
-52.86%
-43.22%
-88.37%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Annexon Inc logo
NA
NA
NA
-1.07
-0.48
-0.28
NA
3.14
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Annexon Inc logo
Buy
$254.8M
-88.37%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Annexon

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Organization
Annexon
Employees
84
CEO
Mr. Douglas Love Esq., J.D.
Industry
Health Technology

Management People of Annexon

NameTitle
Mr. Douglas Love Esq., J.D.
CEO, President & Director
Dr. Dean R. Artis Ph.D.
Chief Scientific Officer & Executive VP
Dr. Ted Yednock Ph.D.
Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board
Ms. Jennifer Lew CPA
Executive VP, CFO & Corporate Secretary
Mr. Michael Overdorf M.B.A.
Executive VP & Chief Business Officer
Mr. Henk-Andre Kroon M.D.
Senior Vice President of Translational Medicine
Dr. Jamie Dananberg M.D.
Executive VP & Chief Medical Officer
Mr. Shikhar Agarwal M.B.A.
Senior VP & Head of Commercial
Dr. Sunil Mehta Pharm.D.
Senior VP of Medical Affairs

Important FAQs about investing in ANNX Stock from India :

What is Annexon share price today?

Annexon share price today stands at $2.78, Open: $2.46 ; Previous Close: $2.47 ; High: $2.79 ; Low: $2.45 ; 52 Week High: $8.40 ; 52 Week Low: $2.39.

The stock opens at $2.46, after a previous close of $2.47. The stock reached a daily high of $2.79 and a low of $2.45, with a 52-week high of $8.40 and a 52-week low of $2.39.

Can Indians buy Annexon shares?

Yes, Indians can invest in the Annexon (ANNX) from India.

With INDmoney, you can buy Annexon at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Annexon at zero transaction cost.

How can I buy Annexon shares from India?

It is very easy to buy Annexon from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Annexon (ANNX) be purchased?

Yes, you can buy fractional shares of Annexon with INDmoney app.

What are the documents required to start investing in Annexon stocks?

To start investing in Annexon, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Annexon Stock (ANNX)?

Today’s highest price of Annexon (ANNX) is $2.79.

Today’s lowest price of Annexon (ANNX) is $2.45.

What is today's market capitalisation of Annexon?

Today's market capitalisation of Annexon ANNX is 254.8M

What is the 52 Week High and Low Range of Annexon Stock (ANNX)?

  • 52 Week High

    $8.40

  • 52 Week Low

    $2.39

What are the historical returns of Annexon (ANNX)?

  • 1 Month Returns

    -29.83%

  • 3 Months Returns

    -57.56%

  • 1 Year Returns

    -52.86%

  • 5 Years Returns

    -88.37%

Who is the Chief Executive Officer (CEO) of Annexon ?

Mr. Douglas Love Esq., J.D. is the current Chief Executive Officer (CEO) of Annexon.